Thrilled to be part of the @MGHCancerCenter’s 2024 Practice-Changing Updates in Hematology Malignancies webinar series! I will be moderating practice-changing updates in lymphoma. Learn more & register: https://t.co/uP7AOeZP5N @MassGenBrighCPD
This work investigating the intersection of palliative care and hematologic malignancies has been so rewarding and I’ve learned so much. Grateful for my collaborators @Areejmd @VjacksonJackson @JasAWebb @tomleblancMD@pconnorjohnson and the support of @MGHPalCareGeri@HMSPallCare
P. Connor Johnson, MD, and Jeremy S. Abramson MD, MMSc, discuss available treatments for patients with Burkitt lymphoma and high-grade B-cell lymphoma. #lymsm | @pconnorjohnson
https://t.co/8HH9eS6OGQ
Great results of supportive care mobile app for patients with AML, led by @Areejmd at @MGHCancerCenter. Demonstrated the feasibility and preliminary efficacy of ehealth/app based supportive care in hospitalized pts with cancer!
Excited to share our phase I/II of tisagenlecleucel in PCNSL: @LLSusa@ASH_hematology@MGHCancerCenter
- Median # of prior therapies = 4
- ORR 58.3% (7/12)
- CR rate 50% (6/12)
- Responses seen beyond 12 months
- Trafficking to CNS by flow and VCN
https://t.co/4l5rfjDeQM
Topping et al found that pts’ inaccurate perception of prognosis can lead to increased utilization of hospital services at the end of life and decreased uptake of #hospice. [2/3s felt they could still be cured despite have advanced disease.]
https://t.co/JmNUkpAR19
#ASCO21 (6/x)
‼️Association between baseline geriatric domains and survival in older adults with chronic lymphocytic leukemia (CLL) #ASCO21@ASCO@RyanNipp@dlage@Areejmd
https://t.co/nppDoQznGk
Retweet this #ASCO21#ConquerCancer collage and tag the doctors you see! Your gift to the #ASCOCONQUERSCANCER Fund supports Grant & Award recipients from around the globe 🌍🌎🌏 https://t.co/NUvFdWLWY7